欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
PT/H/1165/001
药品名称
Levetiracetam Hikma
活性成分
levetiracetam 100.0 mg/ml
剂型
Concentrate for solution for infusion
上市许可持有人
Hikma Farmacêutica (Portugal), S.A.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
France (FR)
Spain (ES)
Germany (DE)
Levetiracetam Hikma 100 mg/ml,Konzentrat zur Herstellung einer Infusionslösung
Austria (AT)
Italy (IT)
许可日期
2014/06/17
最近更新日期
2024/08/23
药物ATC编码
N03AX14 levetiracetam
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
PubAR
|
575900_20140627_PAR_GBB
Date of last change:2024/09/06
Final Product Information
|
common_impack_100mgmljan14_clean
Date of last change:2024/09/06
Final Product Information
|
common_outer_100mgmljan14_clean
Date of last change:2024/09/06
Final Product Information
|
common_pl_100mgmljun14
Date of last change:2024/09/06
Final PL
|
common_pl_levetiracetam_dcp_var016 _tracked_
Date of last change:2024/09/06
Final Product Information
|
common_spc_100mgmljun14
Date of last change:2024/09/06
Final SPC
|
common_spc_levetiracetam_dcp_var016 _tracked_
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase